Méchin M C, Rousset E, Girardeau J P
Laboratoire de Microbiologie, Centre de Recherches de Clermont-Ferrand-Theix, Saint-Genès-Champanelle, France.
Infect Immun. 1996 Sep;64(9):3555-64. doi: 10.1128/iai.64.9.3555-3564.1996.
As a first step toward the design of an epitope vaccine, by using the nonfimbrial adhesin CS31A of Escherichia coli as a carrier, a low-resolution topological and epitope map of the CS31A subunit was developed by using solid-phase peptide synthesis and polyclonal rabbit antibodies raised against both native and denatured proteins. Peptides constituting antigenic epitopes on the major subunit (ClpG) of the multimeric CS31A antigen were identified by examining the binding of the antibodies to 249 overlapping nonapeptides covering the amino acid sequence of ClpG. With antibodies raised against denatured ClpG subunit, seven major epitope regions, corresponding to residues 10 to 18, 45 to 58, 88 to 107, 148 to 172, 187 to 196, 212 to 219, and 235 to 241, were located. Most of the epitopes were hydrophilic and were located in variable regions, residing largely in loop regions at the boundaries of secondary structural elements of ClpG. In contrast, antibodies raised against native CS31A antigen reacted only with the peptide AVNPNA (positions 179 to 184), demonstrating that this peptide was the only linear B-cell epitope of the native protein. The different immunogenic profiles of native CS31A antigen and denatured ClpG indicated that the denaturation process resulted in marked conformational changes in the protein, which could expose epitopes hidden or absent in native CS31A. To identify the surface-exposed epitopes, nine peptides covering the dominant antigenic regions of ClpG were synthesized and used to prepare site-specific antibodies. Antipeptide antibodies were tested, in a competitive enzyme-linked immunosorbent assay (ELISA), for cross-reactivity with native CS31A and denatured ClpG subunit. Four of these antipeptide antibodies bound to the native protein in an accessibility ELISA, indicating that residues 44 to 56, 174 to 190, 185 to 199, and 235 to 249 were surface exposed on CS31A. These data indicate that an immunodominant surface-exposed linear epitope was present in the region from positions 179 to 184 of ClpG in the native CS31A antigen on intact bacterial cells and suggest that the four surface-exposed epitopes constitute potential sites for insertions or substitutions with heterologous peptides.
作为设计表位疫苗的第一步,以大肠杆菌的非菌毛黏附素CS31A为载体,利用固相肽合成法以及针对天然和变性蛋白产生的兔多克隆抗体,绘制了CS31A亚基的低分辨率拓扑和表位图。通过检测抗体与覆盖ClpG氨基酸序列的249个重叠九肽的结合情况,确定了多聚体CS31A抗原主要亚基(ClpG)上构成抗原表位的肽段。利用针对变性ClpG亚基产生的抗体,确定了七个主要表位区域,分别对应于第10至18位、45至58位、88至107位、148至172位、187至196位、212至219位以及235至241位的残基。大多数表位具有亲水性,位于可变区,主要存在于ClpG二级结构元件边界的环区。相比之下,针对天然CS31A抗原产生的抗体仅与肽AVNPNA(第179至184位)发生反应,表明该肽是天然蛋白唯一的线性B细胞表位。天然CS31A抗原和变性ClpG不同的免疫原性特征表明,变性过程导致蛋白质发生显著的构象变化,从而暴露了天然CS31A中隐藏或不存在的表位。为了确定表面暴露的表位,合成了覆盖ClpG主要抗原区域的九个肽段,并用于制备位点特异性抗体。在竞争性酶联免疫吸附测定(ELISA)中检测抗肽抗体与天然CS31A和变性ClpG亚基的交叉反应性。其中四个抗肽抗体在可及性ELISA中与天然蛋白结合,表明第44至56位、174至190位、185至199位以及235至249位的残基在CS31A表面暴露。这些数据表明,在完整细菌细胞上的天然CS31A抗原中,ClpG第179至184位区域存在一个免疫显性的表面暴露线性表位,并表明这四个表面暴露表位构成了用异源肽进行插入或替换的潜在位点。